Explore the top headlines of the month, including insights on the latest clinical trials, therapeutic updates, and more.
Publication|Articles|April 17, 2025
- Dermatology Times, April 2025 (Vol. 46. No. 04)
- Volume 46
- Issue 04
Expert Insights From AAD 2025
From our April issue: Unlock exclusive AAD 2025 insights from top dermatology experts—what you missed and what’s next.
Advertisement
Advertisement
The 2025 American Academy of Dermatology (AAD) Annual Meeting brought together dermatology clinicians from around the globe in Orlando, Florida, for 5 days of clinical updates and networking. From March 7 to 11, this year’s AAD meeting featured more than 330 sessions with countless topics and therapeutic focuses.
Related to this article
Dermatology Times is looking back on the top stories in dermatology from the month of October.
Elevate-Derm Summer 2026 faculty share practical lessons on hair loss exams, PIH, geriatric dermatology, and managing cholesterol rises on JAK inhibitors.
Face taping promises smoother skin and fewer wrinkles without injectables, but evidence suggests any visible benefits are largely temporary.
The 3rd annual meeting in Atlanta gives dermatology NPs and PAs 4 case-based breakout sessions and a general education session in a focused, small-group setting.
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
October brought FDA approvals in urticaria and HSV, new regulatory filings, and phase 3 advances in HS, psoriasis, and rare diseases.
Gaurav Singh, MD, explores how gene expression profiling may improve melanoma risk stratification, surveillance, and individualized care.
Advertisement
Advertisement